Home › NDC Lookup › Ingredients › Aluminum Hydroxide, Magnesium Hydroxide,... › 00904-6700-60
Mintox Plus Tabs Aluminum hydroxide, Magnesium hydroxide, Simethicone 200 mg; 200 mg; 25 mg Tablet, Chewable, 100-count — NDC 00904-6700-60 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Mintox Plus Tabs Aluminum hydroxide, Magnesium hydroxide, Simethicone 200 mg; 200 mg; 25 mg Tablet, Chewable, 100-count — NDC 0904-6700-60 (Billing 00904-6700-60)

by Major Pharmaceuticals · 100 TABLET, CHEWABLE in 1 BOTTLE

This is a package of 100 tablets of Mintox Plus Tabs Aluminum hydroxide, Magnesium hydroxide, Simethicone 200 mg; 200 mg; 25 mg Tablet, Chewable from Major Pharmaceuticals, marketed since Aug 2018 and currently FDA-listed; retail pharmacies pay about $0.0394 per tablet (NADAC). It is this product's only package size.

NDC 00904-6700-60
🏷️ FDA NDC (as labeled) 0904-6700-60 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0904-6700-60 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0904 labeler · 6700 product · 60 package
Package marketed since
Aug 2, 2018
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 0904670060 9
Medicaid fills, this package
22,346 prescriptions in the last four reported quarters
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0904-6700-60
Product NDC 0904-6700
11-digit billing NDC 00904670060
NCPDP billing unit EA — each (per item)
Application # M001
SPL Set ID c72f0736-ee20-45b4-baf0-b80f1e3fa9cb
Established class (EPC) Calculi Dissolution Agent; Osmotic Activity
Mechanism of action Magnesium Ion Exchange Activity
Physiologic effect Increased Large Intestinal Motility; Inhibition Large Intestine Fluid/Electrolyte Absorption; Inhibition Small Intestine Fluid/Electrolyte Absorption
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2018-08-02
Route ORAL
Dosage form TABLET, CHEWABLE
Substance ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE; DIMETHICONE, UNSPECIFIED

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 002708
GCN 63951
HICL code 001168
Ingredient (HICL) Mag Hydrox/Aluminum Hyd/Simeth
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D4
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Alimentary Tract
HIC3 code D4B
Therapeutic class — specific (HIC3) Antacids
AHFS code 56:04.00.00
AHFS class Antacids And Adsorbents
FDB label name MINTOX PLUS TABLET CHEWABLE
FDB brand name Mintox Plus
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 002708
  • GCN: 63951
  • HICL (First Databank): 001168
  • AHFS class code: 56:04.00.00
Why two NDCs? The FDA registers this code as 0904-6700-60 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00904-6700-60. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name MINTOX PLUS TABLET CHEWABLE Ingredient Mag Hydrox/Aluminum Hyd/Simeth
📖 About the active ingredient MedlinePlus · NLM
General information about the ingredient itself — the description of this specific product follows below.

Aluminum hydroxide is used for the relief of heartburn, sour stomach, and peptic ulcer pain and to promote the healing of peptic ulcers.

Read the full MedlinePlus article ↗
🧪 What is this product?

Mintox Plus Tabs is a chewable tablet taken by mouth that contains three active ingredients commonly used for heartburn and indigestion relief. Aluminum hydroxide and magnesium hydroxide are antacids that work to neutralize stomach acid. Simethicone (also called dimethicone) is an anti-gas agent typically included to help reduce bloating and gas discomfort. This product is marketed as an over-the-counter monograph drug, meaning it follows established FDA guidelines for this category of antacid products.

5
Nutrient depletion considerations

Aluminum Hydroxide, Magnesium Hydroxide, Simethicone (OTC drug) may be associated with lower levels of 5 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Aluminum Hydroxide, Magnesium Hydroxide, Simethicone (OTC drug) nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.039 $3.94 / 100 tablets
Medicaid paysCMS SDUD · 12 mo $0.1482 $14.82 / 100 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jun 2021 Feb 2026 May 2026 Sep 2026 $0.040 $0.023
▲ Up 69% over the last 11 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00904-6700-60 You're viewing this Main listing 100 TABLET, CHEWABLE in 1 BOTTLE 2018-08-02 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Mintox Plus Tabs 200 mg/1; 200 mg/1; 25 mgthis 00904-6700-60 Major 100 tablets $0.039 — Availability likely —
Gelusil 200 mg/1; 200 mg/1; 24 mg/1; 1 mg 65197-0300-10 WellSpring 10 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2018
On the market since
Aug 2018
📍
2026
Currently FDA-listed
8 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color White
ShapeRound
ImprintRP133
Size16 mm
ScoringNot scored
FlavorLemon
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII IY9XDZ35W2
    Dextrose is a simple sugar derived from corn or other sources. It serves as a filler and sweetener in medicines to add bulk, improve taste, and help stabilize the medication's form.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 7CVR7L4A2D
    A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 96K6UQ3ZD4
    Sucralose is a synthetic sweetener made from sugar. It's added to medicines to improve taste without adding calories, helping make bitter or unpleasant-tasting drugs easier to take.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesdextrose, flavors, magnesium stearate, maltodextrin, microcrystalline cellulose, silica, sucralose

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMajor Pharmaceuticals
FDA applicationM001 (OTC MONOGRAPH DRUG)
Labeler code00904
First marketedAug 2018
Product typeHuman Otc Drug
Portfolio630 products on file

More NDCs from Major Pharmaceuticals labeler code 00904

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 16 words ▾

Uses Relieves: heartburn sour stomach acid indigestion bloating, pressure and discomfort commonly referred to as gas

⏱️ Dosage and Administration 68 words ▾

Directions adults and children 12 years of age and older: chew 2 to 4 tablets. Repeat hourly if symptoms return, or as directed by a physician . children under 12 years of age : Ask a doctor. do not take more than 12 tablets in a 24- hour period, or use the maximum dosage for more than 2 weeks ,except under the advice and supervision of a physician.

⚠️ Warnings 83 words ▾

Warnings Ask a doctor before use if you have kidney disease a magnesium-restricted diet Ask a doctor or pharmacist before use if you are now taking a prescription drug. Antacids may interact with certain prescription drugs. Stop use and ask a doctor if symptoms last more than 2 weeks.

If Pregnant or breast -feeding ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.

📦 Storage and Handling 17 words ▾

Other information each tablet contains: magnesium 84 mg store at room temperature keep tightly closed and dry

🧪 Active Ingredient 20 words ▾

Active ingredients (in each tablet) Aluminum hydroxide (equivalent to dried gel, USP) 200 mg Magnesium hydroxide 200 mg Simethicone 25mg

🧪 Inactive Ingredients 11 words ▾

Inactive ingredients dextrose, flavors, magnesium stearate, maltodextrin, microcrystalline cellulose, silica, sucralose

🎯 Purpose 4 words ▾

Purpose Antacid Antacid Antigas

📄 Ask a Doctor Before Use If 13 words ▾

Ask a doctor before use if you have kidney disease a magnesium-restricted diet

📄 Ask a Doctor or Pharmacist Before Use If 22 words ▾

Ask a doctor or pharmacist before use if you are now taking a prescription drug. Antacids may interact with certain prescription drugs.

📄 Stop Use and Ask a Doctor If 13 words ▾

Stop use and ask a doctor if symptoms last more than 2 weeks.

🤰 If Pregnant or Breast-Feeding 11 words ▾

If Pregnant or breast -feeding ask a health professional before use.

📄 Keep Out of Reach of Children 23 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.

📄 Questions or Comments 6 words ▾

Questions or comments? Call : (800)-616-2471

📄 Package Label / Principal Display Panel 82 words ▾

Principal Display Panel MAJOR ® Mintox™ Plus Tabs ANTACID PLUS ANTI-GAS FAST RELIEF OF: ACID INDIGESTION HEARTBURN SOUR STOMACH GAS Lemon Mint Naturally and Artificially Flavored GREAT TASTE! 100 TABLETS Compare to the Active Ingredients in Maalox ® Plus* Distributed by: Major ® Pharmaceuticals 17177N Laurel park drive, Suite 233 Livonia, MI 48152 USA *This product is not manufactured or distributed by Novartis Consumer Health Inc, the distributor of Maalox ® plus. Mintox Plus Tabs Antacid Plus Anti-Gas Lemon Mint 100 Tablets

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
22.3K
Units reimbursed last 4 qtrs
2.3M
Gross reimbursed last 4 qtrs
$340.6K
Avg / prescription
$15.24
Avg / unit
$0.1482
Latest quarter Q1 2026
1.9KRx
Medicaid pays / ea
$0.1482
gross reimbursed
vs
NADAC / ea
$0.0394
acquisition cost
=
Spread
+$0.1088
+276% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
99% FFS
Fee-for-service · 22,035 Rx Managed care · 311 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 2,888 units · 50.3 per 100k residents MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: 1,300 units · 40.7 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 260 units · 3.8 per 100k residents IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: 2,282,620 units · 5,858 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: 10,676 units · 35.0 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
3.85,858
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 California 5,858 /100k
2 Minnesota 50.3 /100k
3 Nevada 40.7 /100k
4 Texas 35.0 /100k
5 Indiana 3.8 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Mintox Plus Tabs (this brand).

Top reported reactions

Electrocardiogram Qt Prolonged4
Drug Interaction2
Drug Level Increased2
Schizoaffective Disorder2
Abdominal Discomfort1
Abdominal Distension1
Abdominal Pain1

Reporter sex

7 reports
Male · 33%
Female · 67%

Serious outcomes

Hospitalization5
Life-threatening1
Disabling1
Death1
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 1 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 00904-6678-40 · MAJOR 00904-6704-61 · Major →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.